Who Paid My Doc
Nathan Brown
Oral & Maxillofacial Surgery Slidell, LA Doctor of Dentistry
NPI 1336385020 CMS profile 942307
1271 7Th St, Slidell, LA 70458
General payments
$9,267
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Nathan Brown of Slidell, LA is reported in the CMS Open Payments database as having received $9,267 across 126 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 90th percentile of Oral & Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $1,121 | 24 | |
| 2024 | General | $567 | 12 | |
| 2023 | General | $349 | 12 | |
| 2022 | General | $3,093 | 16 | |
| 2021 | General | $1,387 | 21 | |
| 2020 | General | $2,403 | 26 | |
| 2019 | General | $346 | 15 |
Beside peers
- Nathan Brown
- Oral & Maxillofacial Surgery median
- Middle half of Oral & Maxillofacial Surgery
- National median
In program year 2025, general payments to Nathan Brown were reported at $1,121. Among 792 Oral & Maxillofacial Surgery profiles paid that year, the median was $184 and the middle half received between $61 and $541.
Show as a table
| Year | Nathan Brown | Oral & Maxillofacial Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $346 | $178 | $56–$584 | $163 |
| 2020 | $2,403 | $106 | $38–$316 | $114 |
| 2021 | $1,387 | $165 | $57–$511 | $132 |
| 2022 | $3,093 | $173 | $63–$494 | $149 |
| 2023 | $349 | $184 | $62–$521 | $160 |
| 2024 | $567 | $197 | $65–$603 | $164 |
| 2025 | $1,121 | $184 | $61–$541 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 7 drugsPart D claims
493
Drug cost
$2,589
Branded share of claims
33.5%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav | Brand | 84 | $718 | |
| Amoxicillin | Generic | 230 | $616 | |
| Moxifloxacin Hcl | Generic | 13 | $561 | |
| Metronidazole | Generic | 24 | $198 | |
| Chlorhexidine Gluconate | Generic | 39 | $188 | |
| Clindamycin Hcl | Generic | 22 | $158 | |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | Brand | 81 | $151 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 600 Part D prescribers listed as Oral & Maxillofacial Surgery; they describe a distribution and say nothing about conduct.
Records
126 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Oral & Maxillofacial Surgery in Louisiana
Waleed Zaid
Oral & Maxillofacial Surgery · Baton Rouge, LA
Jennifer Woerner
Oral & Maxillofacial Surgery · Shreveport, LA
Dongsoo Kim
Oral & Maxillofacial Surgery · Shreveport, LA
Ghali Ghali
Oral & Maxillofacial Surgery · Shreveport, LA
Andrei Marechek
Oral & Maxillofacial Surgery · Baton Rouge, LA
Samuel Allen
Oral & Maxillofacial Surgery · Shreveport, LA
Related records
Oral & Maxillofacial Surgery in Louisiana
Practitioners in the same specialty and state, ranked by reported value.
All Oral & Maxillofacial Surgery
Everyone recorded under this specialty, nationwide.
Doctors in Louisiana
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.